Tag

en US- Pagina 641

The Adecco Group: Q1 2023 Results

giovedì, 4 Maggio 2023
(Adnkronos) – AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange  ZURICH, May 4, 2023 /PRNewswire/ — Q1 2023 Results   Delivering strong market share gains, revenue growth and gross

Taiho Oncology and Servier Announce Publication in the New England Journal of Medicine of Pivotal Phase 3 Data for Trifluridine/Tipiracil (LONSURF®) in Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer

giovedì, 4 Maggio 2023
(Adnkronos) – PRINCETON, N.J. and PARIS, May 4, 2023 /PRNewswire/ — Taiho Oncology, Inc. and Servier today announced the publication of results from the pivotal Phase 3 SUNLIGHT* clinical trial of trifluridine/tipiracil